Please login to the form below

Not currently logged in
Email:
Password:

Elan promotes president of R&D to board

Irish biotech Elan has hired Dr Lars Ekman, who is currently president of R&D, to the position of member of the operating committee and the board of directors

Irish biotech Elan has hired Dr Lars Ekman, who is currently president of R&D, to the position of member of the operating committee and the board of directors.

Dr Ekman will transition from his current operational role to become an advisor as a member of the board of directors from 31 December 2007. He will continue to chair the science and technology committee on matters relating to Elan's research platform and portfolio. Other board members include Dr Dennis Selkoe and Dr Floyd Bloom.

Ekman will remain an integral part of the company's science, clinical development and corporate activities and will continue as key senior spokesperson for Elan as president of R&D. He will also continue as co-chair on the joint steering committee with US-based pharmaceutical company Wyeth. Ekman's responsibility will be to focus on Elan's intermediate and long-term plans as he dedicates his time to provide strategic advice to the chairman and the CEO in his continuing role as a member of the board of directors.

Ekman joined Elan in January 2001 after holding a number of senior executive positions in the pharmaceutical industry. During this period, Elan received approval for four US NDAs, three EU marketing approval applications and five iNDAs. His efforts have seen the drugs Prialt and Tysabri come to market and progressing further several of Elan's Alzheimer's immunotherapy programmes.

9th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics